Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07504341

Physiological Finding in Management of COVID 19 Patients

The Combined Usage of Clinical Physiological Finding in Management of COVID 19 Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
15,000 (estimated)
Sponsor
St. Martin De Porress Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Detailed description

This study utilizes physiological indicators of COVID-19 patients, such as blood pressure, heart rate, respiratory rate, and level of consciousness, to develop Shock Index (SI), Mordified Shock Index (MSI), Age Shock Index (Age SI), Age Mordified Shock Index (Age MSI), and Respiratory Adjusted Shock Index (RASI), as well as other physiological indicators, as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. For patients with mild to severe illness, and in response to the shortage of manpower during a large influx of emergency patients, this study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Conditions

Interventions

TypeNameDescription
OTHERphysiological parameterssystolic blood pressure, diastolic blood pressure , heart rate, respiratory rate , GCS

Timeline

Start date
2026-04-01
Primary completion
2027-03-11
Completion
2027-03-31
First posted
2026-03-31
Last updated
2026-03-31

Locations

2 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07504341. Inclusion in this directory is not an endorsement.